Maude et al. BLOOD, 25 JUNE 2015 x VOLUME 125, NUMBER 26.
Optimal use of rituximab in aggressive NHL Professor Michael Pfreundschuh.
Resistance to Imatinib in Chronic Myelogenous Leukemia (CML): Mutations and Beyond
Disclosures
Clinical Writing for Interventional Cardiologists
THE ECHOCARDIOGRAPHIC EVALUATION OF THE HEART FAILURE PATIENT Prof. Patrizio Lancellotti, MD, PhD, University hospital, CHU Sart Tilman, Liège.
מחלות המסתם האאורטלי דן גילון 23.10.2013
Inflammation Following Percutaneous Coronary Interventions
Treatment Approaches in Relapsed CML
